Stoxx Europe 50

Stoxx Europe 50 handeln
4.906,33 PKT -60,88 PKT -1,23 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 965816

ISIN EU0009658160


Analysen zu Stoxx Europe 50-Werten

Datum Rating Analyst
06.01.23 Rheinmetall Overweight JP Morgan Chase & Co.
06.01.23 ASML NV Buy Jefferies & Company Inc.
06.01.23 AstraZeneca Neutral Credit Suisse Group
06.01.23 Roche Outperform Credit Suisse Group
06.01.23 Novartis Underperform Credit Suisse Group
06.01.23 Sanofi Outperform Credit Suisse Group
06.01.23 GSK Neutral Credit Suisse Group
06.01.23 Shell (ex Royal Dutch Shell) Buy UBS AG
06.01.23 Sanofi Equal-weight Morgan Stanley
06.01.23 Unilever Buy Jefferies & Company Inc.
06.01.23 Rolls-Royce Buy Jefferies & Company Inc.
06.01.23 HSBC Buy Jefferies & Company Inc.
06.01.23 Shell (ex Royal Dutch Shell) Buy Jefferies & Company Inc.
06.01.23 ASML NV Buy Jefferies & Company Inc.
06.01.23 UniCredit Buy Jefferies & Company Inc.
06.01.23 SAP Underperform Jefferies & Company Inc.
06.01.23 Shell (ex Royal Dutch Shell) Buy Jefferies & Company Inc.
06.01.23 Shell (ex Royal Dutch Shell) Outperform RBC Capital Markets
06.01.23 Novartis Underweight Morgan Stanley
06.01.23 UBS Outperform RBC Capital Markets
05.01.23 UBS Overweight JP Morgan Chase & Co.
05.01.23 Deutsche Telekom Overweight Barclays Capital
05.01.23 AstraZeneca Overweight JP Morgan Chase & Co.
05.01.23 Münchener Rückversicherungs-Gesellschaft Sector Perform RBC Capital Markets
05.01.23 ASML NV Buy UBS AG
05.01.23 EssilorLuxottica Outperform Bernstein Research
05.01.23 Richemont Market-Perform Bernstein Research
05.01.23 LVMH Moet Hennessy Louis Vuitton Outperform Bernstein Research
05.01.23 Air Liquide Buy UBS AG
05.01.23 Schneider Electric Buy Deutsche Bank AG
05.01.23 Richemont Overweight Barclays Capital
05.01.23 LVMH Moet Hennessy Louis Vuitton Overweight Barclays Capital
05.01.23 Hermès (Hermes International) Overweight Barclays Capital
05.01.23 AstraZeneca Hold Jefferies & Company Inc.
05.01.23 GSK Hold Jefferies & Company Inc.
05.01.23 Novo Nordisk Underperform Jefferies & Company Inc.
05.01.23 Novartis Buy Jefferies & Company Inc.
05.01.23 Sanofi Buy Jefferies & Company Inc.
05.01.23 Roche Hold Jefferies & Company Inc.
05.01.23 HSBC Buy Jefferies & Company Inc.